International Clinical Trial: Real-world outcomes and early progression prediction of first-line systemic therapy in advanced/unresectable pancreatic ductal adenocarcinoma: an retrospective cohort study (RWS-01)

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133499) titled 'Real-world outcomes and early progression prediction of first-line systemic therapy in advanced/unresectable pancreatic ductal adenocarcinoma: an retrospective cohort study (RWS-01)' on Sept. 28.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Condition: Advanced/unresectable pancreatic ductal adenocarcinoma

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: First-line systemic therapy cohort (advanced/unresectable PDAC):600;

Countries of Recruitment: China

To know mo...